Skip to main content
Book cover

90. Kongreß pp 849–868Cite as

Kardiologie II

  • Conference paper
  • 32 Accesses

Part of the book series: Verhandlungen der Deutschen Gesellschaft für Innere Medizin ((VDGINNERE,volume 90))

Zusammenfassung

Konsekutive ventrikuläre Herzthythmusstörungen basieren nach heutigem Erkenntnisstand vorwiegend auf Reentry-Mechanismen. Funktionelle Voraussetzung für solche Wiedereintrittsphänomene ist die unidirektionale Blockierung der Erregungsausbreitung in einem umschriebenen Myokardbezirk [1, 3, 11]. Bei lokaler Ableitung stellt sich eine solche Depolarisationsstörung als fraktioniertes Ventrikelpotential bzw. — bei stärkerer zeitlicher Distanzierung — als ventrikuläres Spätpotential dar. Diese ventrikulären Spätpotentiale sind demnach als direkter Ausdruck einer lokalen Leitungsverzögerung und damit einer funktionell präformierten Reentrybahn anzusehen.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Boineau JP, Cox JL (1973) Slow ventricular activation in acute myocardial infarction. A source of reentrant premature ventricular contractions. Circulation 48: 702

    Google Scholar 

  2. Breithardt G, Bürggrefe M, Karbenn U, Haerten K, Ostermeyer J, Seipel L (1983) Die mögliche Bedeutung von Spätpotentialen für die Identifizierung von Patienten, die einer antiarrhythmischen Therapie bedürfen. In Schlepper M, Olsson B (Hrsg) Kardiale Rhythmusstörungen, Diagnose, Prognose, Therapie. Springer, Berlin Heidelberg New York, S 39

    Google Scholar 

  3. Durrer D, van Lier A, Buller J (1964) Epicardial and intramural excitation in chronic myocardial infarction. Am Heart J 68: 765

    Article  PubMed  CAS  Google Scholar 

  4. El-Sherif N, Mehra R, Gomez JAZ, Kelen K (1983) Approisal of a low noise electrocardiogram. J Am Coll Cardiol 1: 456

    Article  PubMed  CAS  Google Scholar 

  5. EI-Sherif N, Scherlag BJ, Lazzara R, Hope RR (1977) Reentrant ventricular arrhythmias in the late myocardial period. 1. Conduction characteristics in the infarction zone. Circulation 55: 686

    Google Scholar 

  6. Flowers NC, Shvartsman V, Sohi G, Horan LG (1981) Signal averaged versus beat-to-beat recording of surface His-Purkinje potentials. In: Hombach V, Higer HH (eds) Signal averaging technique in clinical cardiology. Schattauer, Stuttgart New York, p 329

    Google Scholar 

  7. Höpp HW, Hombach V, Kebbel U, Osterspey A., Deutsch HJ, Winter U, Hirche HJ, Hilger HH (1983) Die klinische Bedeutung der kontinuierlichen Registrierung ventrikulärer Spätpotentiale von der Körperoberfläche. Z Kardiol (Suppl l) 72: 106

    Google Scholar 

  8. Höpp HW, Hombach V, Braun V, Behrenbeck DW, Tauchert M, Hilger HH (1981) Ventricular delayed depolarizations in patients with chronic stable coronary heart disease and with acute myocardial infarction. In: Hombach V, Hilger HH (eds) Signal averaging technique in clinical cardiology. Schattauer, Stuttgart New York, p 233

    Google Scholar 

  9. Höpp HW, Hombach V, Braun V, Behrenbeck DW, Tauchert M, Hilger HH (1981) Ventricular delayed depolarizations in patients with chronic stable coronary heart disease and with acute myocardial infarction. In: Hombach V, Hilger HH (eds) Signal averaging technique in clinical cardiology. Schattauer, Stuttgart New York, p 233

    Google Scholar 

  10. Oeff M, v. Leitner ER, Erne SN, Halbohm HP, Lehmann HP, Schröder R (1982) Einzelschlagregistrierung ventrikulärer Spätpotentiale von der Körperoberfläche koronarkranker Patienten. Z Kardiol 71: 627

    Google Scholar 

  11. Scherlag BJ, El-Sherif N, Hope R, Lazzara R: Characterization and localization of ventricular arrhythmias resulting from myocardial ischemia and infarction. Circ Res 53: 372

    Google Scholar 

  12. Breithardt G et al (1981a) Clinical significance of ventricular late potentials. In: Hombach V, Hilger HH (eds) Signal averaging technique in clinical cardiology. Schattauer, Stuttgart New York, p 219ff

    Google Scholar 

  13. Breithardt G et al. (1981b) Eur Heart J 2: 1–11

    Article  PubMed  CAS  Google Scholar 

  14. Breithardt G et al. (1982) Am J Cardiol 49: 1932–1937

    Article  PubMed  CAS  Google Scholar 

  15. Breithardt G et al. (1983) Comparison between late potentials, programmed ventricular stimulation and left ventricular function in patients without documented ventricular tachycardia: relation to prognosis. In: International Workshop in Altenberg. Abstract No. 34a

    Google Scholar 

  16. Höpp H-W et al. (1981) Ventricular delayed depolarisations in patients-with chronic stable coronary artery disease and with acute myocardial infarction. In: Hombach V, Hilger HH (eds) Signal averaging technique in clinical cardiology. Schattauer, Stuttgart New York, p 219ff

    Google Scholar 

  17. Höpp H-W et al. (1982) Ventrikuläre Spätpotentiale bei Patienten mit chronischer koronarer Herzkrankheit. Herzmedizin 5: 11–35

    Google Scholar 

  18. Hombach V et al. (1980) Die Bedeutung von Nachpotentialen innerhalb des St-Segmentes im Oberflächen-EKG bei Patienten mit KHK. Dtsch Med Wochenschr 42: 1457–1462

    Article  Google Scholar 

  19. Hombach V et al. (1983) Clinical value of beat-to-beat registrations of ventricular late potentials as compared to the signal averaging technique. In: International workshop in Altenberg. Abstract No. 29a Höpp, H.-W., Osterspey, A., Hombach, V., Winter, U. J., Hilger, H. H. (Med. Univ.-Klinik I II, Kardiologie, Universität Köln )

    Google Scholar 

  20. Bexton RS, Camm AJ (1982) Drugs with a class III antiarrhythmic action. Pharmacol Ther [B] 17: 315

    Article  CAS  Google Scholar 

  21. Burckhardt D, Pfisterer M, Hoffmann A, Burkart F, Emmenegger H, Jost M, Bolli P, Buehler FR (1983) Effects of the beta-adrenoceptorblocking agent Sotalol on ventricular arrhythmias in patients with chronic ischemic heart disease. A placebo-controlled, double-blind cross-over study. Cardiology (Suppl 1 ) 70: 114

    Article  Google Scholar 

  22. Heddle B, Green M, Brugada P, Wellens H (1982) Electrophysiology of intravenous Sotalol in man. Circulation (Suppl. 2 ) 66: 372

    Google Scholar 

  23. Julian DG, Jackson FS, Prescott RJ, Szekely P (1982) Controlled trial of Sotalol for one year after myocardial infarction. Lancet 82: 1142

    Article  Google Scholar 

  24. Nademanee A, Feld G, Hendrickson JA, Intarachot V, Singh B (1983) Electrophysiology and antiarrhythmic effects of sotalol in patients with refractory life-threatening ventricular tachyarrhythmias. Circulation (Suppl. 3 ) 68: 271

    Google Scholar 

  25. Senges J, Lengfelder W, Jauernig R, Czygan E, Brachmann J, Rizos I, Cobbe S, Kübler W (1984) Electrophysiologic testing in assessement of therapy with sotalol for sustained ventricular tachycardia. Circulation 69: 577

    Article  PubMed  CAS  Google Scholar 

  26. Vaughan Williams EM (1970) Classification of antiarrhythmic drugs. In: Sandoe E, Flensted-Jensen E, Olsen KH (eds) Cardiac arrhythmias. Astra, Södertälje Nitsch, J., Luderitz, B. (Med. Univ.-Klinik Bonn, Innere Medizin/Kardiologie )

    Google Scholar 

  27. Andreasen F, Agerbaek H, Bjerregard P, Gotzsche H (1981) Pharmacokinetics of amiodarone after intravenous and oral administration. Eur J Clin Pharmacol 19: 293

    Article  PubMed  CAS  Google Scholar 

  28. Debbas NMG, Bexton RS, du Cailar C, Puech P, Camm AJ (1983) Relation between myocardial amiodarone concentration and QT interval. Br Heart J 49: 297

    Google Scholar 

  29. Flanagan RJ, Storey GCA, Holt DW (1980) Rapid HPLC method for the measurement of amiodarone in blood plasma or serum at the concentrations attained during therapy. J Chromatogr 12: 391

    Google Scholar 

  30. Graboys TB, Podrid PJ, Lown B (1983) Efficacy of amiodarone for refractory supraventricular tachyarrhythmias. Am Heart J 106: 870

    Article  PubMed  CAS  Google Scholar 

  31. Haffajee CI, Love JC, Canada AT, Lesko LJ, Asdourian G, Alpert JS (1983) Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. Circulation 67: 1347

    Article  PubMed  CAS  Google Scholar 

  32. Harris L, McKenna J, Rowland E, Holt W, Storey CA, Krikler M (1983) Side effects of long-term amiodarone therapy. Circulation 67: 45

    Article  PubMed  CAS  Google Scholar 

  33. Heger JJ, Prystowsky NE, Zipes DP (1983) Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation. Am Heart J 106: 887

    Article  PubMed  CAS  Google Scholar 

  34. Prystowsky N, Zipes P (1984) Plasma and red blood cell concentrations of amiodarone during chronic therapy. Am J Cardiol 53: 912

    Article  PubMed  Google Scholar 

  35. Horowitz LN, Spielman SR, Greenspan AM, Webb CR, Kay HR (1983) Ventricular arrhythmias: Use of electrophysiologic studies. Am Heart J 106: 881

    Google Scholar 

  36. Lüderitz B, Manz M, Steinbeck G (1983) Medikamentöse Langzeittherapie bei ventrikulären Herzthythmusstörungen. Dtsch Med Wochenschr 108: 1663

    Article  PubMed  Google Scholar 

  37. Nademanee K, Hendrickson JA, Intarachot V, Hershman, J. Singh BN (1983) Die Bedeutung der Serumspiegel von reversem T3 unter Amiodaron-Therapie. In: Breithardt G, Loogen F (Hrsg) Neue Aspekte in der medikamentösen Behandlung von Tachyarrhythmien. Urban & Schwarzenberg, München Wien Baltimore, S 277

    Google Scholar 

  38. Nademanee K, Kannan R, Wagner R, Intarachot V, Hendrickson JA, Singh BN (1983) Role of amiodarone and desethylamiodarone and reverse T3 serum levels in monitoring antarrhythmic efficacy and toxicity. Superiority of rT3 and desethylamiodaron levels. Circulation 68: 278

    Google Scholar 

  39. Nitsch J, Manz M, Steinbeck G, Lüderitz B (1983) Amiodaronkonzentrationen im Serum und Gewebe bei ventrikulären Arrhythmien. Verh Dtsch Ges Inn Med 89: 586

    Google Scholar 

  40. Nitsch J, Lüderitz B (1984) Kontrolle der antiarrhythmischen Therapie mit Amiodaron — Bedeutung der Serumspiegelbestimmungen. Dtsch Med Wochenschr 13: 492

    Article  Google Scholar 

  41. Cohn LH, Mason DT, Ross J, Morrow AG, Braunwald E (1967) Preoperative assessement of aortic regurgitation in patients with mitral valve disease. Am J Cardiol 19: 177–182

    Article  PubMed  CAS  Google Scholar 

  42. Gorlin R, Gorlin G (1951) Hydraulic formula for calculation of area of stenotic mitral valve, other cardiac valves and central circulatory shunts. Am Heart J 41: 1–49

    Article  PubMed  CAS  Google Scholar 

  43. Ross J, Braunwald E (1968) Aortic stenosis. Circulation 37 /38: 61–67

    Google Scholar 

  44. Ryan TJ, Lown B, Horn H (1975) Comparison of ventricular ectopic activity during 24-hour monitoring and exercise testing in patients with coronary heart disease. N Engl J Med 292: 224–229

    Article  PubMed  CAS  Google Scholar 

  45. Schwartz LS, Goldfischer J, Sprague GJ, Schwartz SP (1969) Syncope and sudden death in aortic stenosis. Am J Cardiol 23: 647–658

    Article  PubMed  CAS  Google Scholar 

  46. Anderson GJ (1982) Antiarrhythmic actions of amiodarone. Clin Pharmacol Ther 24: 178

    Google Scholar 

  47. Andresen D, Tietze U, von Leitner ER, Lehmann HU, Thormann J, Schröder R (1980) Spontanvariabi1ität tachykarder Rhythmusstörungen. Z Kardiol 69: 214

    Google Scholar 

  48. Burger A, Dinichett C, Nicod P et al. (1976) Effect of amiodarone on serum trijodthyronine, reverse trijodthyronine, thyroxine, and thyrotropine. A drug influencing peripheral metabolism of thyroid hormones. J Clin Invest 58: 255

    Google Scholar 

  49. Flanagan RJ, Storey GCA, Holt DW (1980) Rapid HPLC method for the measurement of amiodarone in blood plasma or serum at the concentrations attained drug therapy. J Chromatogr 12: 391

    Google Scholar 

  50. Graboys ThB, Podrid Ph, Lown B (1982) Effectiveness of amiodarone for refractory atrial tachyarrhythmia. Am J Cardiol 49: 981

    Article  Google Scholar 

  51. Haffajee CI, Love JC, Canada AT, Lesko LJ, Asdburian GK, Alpert JS (1983) Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. Circulation 67: 1347

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Höpp, HW. et al. (1984). Kardiologie II. In: 90. Kongreß. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 90. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-85457-6_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85457-6_40

  • Publisher Name: J.F. Bergmann-Verlag, Munich

  • Print ISBN: 978-3-8070-0342-9

  • Online ISBN: 978-3-642-85457-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics